We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
Cap. Flow
+$225M
Cap. Flow %
1.61%
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$98.9M
2
GE icon
GE Aerospace
GE
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
WBA
Walgreens Boots Alliance
WBA
+$67.4M
5
TPR icon
Tapestry
TPR
+$60.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 14.16%
3 Financials 12.66%
4 Industrials 9.8%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
51
Target
TGT
$62.1B
$105M 0.75%
1,662,893
+40,912
+3% +$2.62M
MTZ icon
52
MasTec
MTZ
$26.7B
$103M 0.74%
3,160,116
C icon
53
Citigroup
C
$222B
$102M 0.73%
1,960,569
+45,972
+2% +$2.33M
EFA icon
54
iShares MSCI EAFE ETF
EFA
$76.4B
$102M 0.73%
1,515,782
+1,371,998
+954% +$89.6M
COR icon
55
Cencora
COR
$60.3B
$101M 0.73%
1,440,501
-387,221
-21% -$26M
OMC icon
56
Omnicom Group
OMC
$22.7B
$100M 0.72%
1,346,490
-40,750
-3% -$2.8M
SCZ icon
57
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$98.1M 0.7%
1,924,967
-500,000
-21% -$24.8M
BBWI icon
58
Bath & Body Works
BBWI
$4.01B
$96.4M 0.69%
1,929,856
+54,730
+3% +$2.74M
HUB.B
59
DELISTED
HUBBELL INC CL-B
HUB.B
$96M 0.69%
881,160
+3,362
+0.4% +$359K
LMT icon
60
Lockheed Martin
LMT
$134B
$95.6M 0.68%
642,873
+639,975
+22,083% +$86.9M
CFN
61
DELISTED
CAREFUSION CORPORATION
CFN
$95.4M 0.68%
2,395,494
-21,045
-0.9% -$818K
WDC icon
62
Western Digital
WDC
$179B
$95.2M 0.68%
1,501,814
-11,206
-0.7% -$626K
COP icon
63
ConocoPhillips
COP
$147B
$95.1M 0.68%
1,346,532
+39,402
+3% +$2.83M
GE icon
64
GE Aerospace
GE
$367B
$82.3M 0.59%
612,946
-761,810
-55% -$95.9M
ANF icon
65
Abercrombie & Fitch
ANF
$4.17B
$81.1M 0.58%
2,465,170
-411,935
-14% -$14.2M
ACN icon
66
Accenture
ACN
$89.9B
$81M 0.58%
985,864
+28,142
+3% +$2.13M
NTAP icon
67
NetApp
NTAP
$32.9B
$80.3M 0.58%
1,952,228
-770,223
-28% -$31.3M
E icon
68
ENI
E
$76B
$78.3M 0.56%
1,615,833
-33,931
-2% -$1.62M
VIAB
69
DELISTED
Viacom Inc. Class B
VIAB
$77.1M 0.55%
883,233
-7,763
-0.9% -$641K
BCM
70
DELISTED
iPath Pure Beta Broad Commodity ETN
BCM
$76.1M 0.55%
+1,927,069
New +$76.4M
COL
71
DELISTED
Rockwell Collins
COL
$75.5M 0.54%
1,021,251
+1,505
+0.1% +$107K
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
$74.9M 0.54%
1,306,126
-1,157,952
-47% -$67.4M
GILD icon
73
Gilead Sciences
GILD
$161B
$74.1M 0.53%
986,492
+2,110
+0.2% +$147K
GNRC icon
74
Generac Holdings
GNRC
$11.9B
$72.9M 0.52%
+1,287,380
New +$62.9M
NLSN
75
DELISTED
Nielsen Holdings plc
NLSN
$72.9M 0.52%
1,588,951
-1,274,674
-45% -$52M

Similar funds

Bessemer Group's Q4 2013 Portfolio in Review

As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
  • Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
  • Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
  • Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
  • Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
  • Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
  • Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.

Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.